Strs Ohio Cytom X Therapeutics, Inc. Transaction History

Strs Ohio

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$1.53 - $2.89 $163,557 - $308,941	-106,900 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$4.32 - $6.43 $38,448 - $57,227	-8,900 Reduced 7.69%	106,900 $544,000
Q2 2021 Jul 26, 2021	BUY	$6.33 - $9.91 $170,277 - $266,579	26,900 Added 30.26%	115,800 $733,000
Q4 2020 Jan 25, 2021	BUY	$6.47 - $7.9 $75,699 - $92,430	11,700 Added 15.16%	88,900 $582,000
Q3 2020 Dec 14, 2020	BUY	$6.55 - $8.83 $138,205 - $186,313	21,100 Added 37.61%	77,200 $513,000
Q2 2020 Jul 23, 2020	BUY	$7.4 - $14.64 $34,040 - $67,344	4,600 Added 8.93%	56,100 $467,000
Q4 2019 Jan 24, 2020	SELL	$5.17 - $8.91 $43,428 - $74,844	-8,400 Reduced 14.02%	51,500 $427,000
Q2 2019 Jul 25, 2019	BUY	$9.35 - $11.41 $39,270 - $47,922	4,200 Added 7.54%	59,900 $672,000
Q1 2019 Apr 19, 2019	BUY	$9.5 - $19.16 $169,100 - $341,048	17,800 Added 46.97%	55,700 $598,000
Q2 2018 Aug 06, 2018	BUY	$21.38 - $29.68 $230,904 - $320,544	10,800 Added 39.85%	37,900 $866,000
Q1 2018 Apr 20, 2018	SELL	$21.76 - $34.22 $204,544 - $321,668	-9,400 Reduced 25.75%	27,100 $770,000
Q4 2017 Jan 23, 2018	SELL	$19.0 - $23.09 $77,900 - $94,669	-4,100 Reduced 10.1%	36,500 $770,000
Q3 2017 Oct 23, 2017	BUY	$13.53 - $18.17 $549,318 - $737,702	40,600	40,600 $737,000

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.